跳到正文
原文
The Lancet Gastroenterology & Hepatology· Sheraz Yaqub, Morten Valberg, Bjørn Atle Bjørnbeth, Jon-Helge Angelsen, Kristoffer Watten Brudvik, Ina Andrassy Eilertsen, Richard Fristedt, Claus Wilki Fristrup, Stefan Gilg, Oskar Hemmingsson, Bengt Isaksson, Ingebjørg Soterud Juel, Anders Riegels Knudsen, Peter Nørgaard Larsen, Kim Erlend Mortensen, Inge Christoffer Olsen, Per Sandström, Oddvar Mathias Sandvik, Ernesto Sparrelid, Helena Taflin, Ragnhild A Lothe, Kjetil Taskén, The ASAC Study Group·· 2026-09-24AI 评分23

术后使用阿司匹林治疗结直肠癌肝转移的 ASAC 三期临床试验结果

[Articles] Aspirin after curative-intent treatment of colorectal cancer liver metastases (ASAC): a multicentre, phase 3, randomised, double-blind, placebo-controlled trial

AI 导读

三期临床试验结果显示,术后使用阿司匹林未能改善无病生存期,并与总体生存率降低及更多严重不良事件相关,不支持术后常规使用阿司匹林治疗结直肠癌肝转移。

来源:The Lancet Gastroenterology & Hepatology · thelancet.com